MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation

Circulation

Volumn 122, Issue 23, 2010, Pages 2378-2387

  Lu, Yanjie ^a   Zhang, Ying ^a   Wang, Ning ^a   Pan, Zhenwei ^a   Gao, Xu ^a   Zhang, Fengmin ^a   Zhang, Yong ^a   Shan, Hongli ^a   Luo, Xiaobin ^a   Bai, Yunlong ^a   Sun, Lihua ^a   Song, Wuqi ^a   Xu, Chaoqian ^a   Wang, Zhiguo ^a   Yang, Baofeng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

arrhythmia; atrial fibrillation; gene expression; ion channels; pacing

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL L TYPE ALPHA 1C; CALCIUM CHANNEL L TYPE BETA1; LUCIFERASE; MICRORNA; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADENOVIRUS INFECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACNA1C GENE; CACNB1 GENE; CALCIUM CURRENT; CONTROLLED STUDY; DOG; DOWN REGULATION; ENZYME ASSAY; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART MUSCLE POTENTIAL; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATIC HEART DISEASE; TRANSGENIC MOUSE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ATRIAL FIBRILLATION; CALCIUM CHANNELS, L-TYPE; DISEASE MODELS, ANIMAL; DOGS; ELECTROCARDIOGRAPHY; FEMALE; GENE TARGETING; HEART ATRIA; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MICRORNAS; PREGNANCY; RHEUMATIC HEART DISEASE; VENTRICULAR REMODELING;

EID: 78650701405     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.958967     Document Type: Article

References (48)

1. Nattel S. New ideas about atrial fibrillation 50 years on. Nature. 2002; 415:219-226.
2. Nattel S. Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation. Cardiovasc Res. 1999;42:298-308.
3. Yue L, Feng J, Gaspo R, Li GR, Wang Z, Nattel S. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res. 1997;81:512-520.
4. 2+ currents and human atrial fibrillation. Circ Res. 1999;85:428-436.
5. Chou CC, Nihei M, Zhou S, Tan A, Kawase A, Macias ES, Fishbein MC, Lin SF, Chen PS. Intracellular calcium dynamics and anisotropic reentry in isolated canine pulmonary veins and left atrium. Circulation. 2005; 111:2889-2897.
6. Burashnikov A, Antzelevitch C. Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity. Circulation. 2003; 107:2355-2360.
7. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation: time course and mechanisms. Circulation. 1996;94: 2968-2974.
8. Schotten U, Ausma J, Stellbrink C, Sabatschus I, Vogel M, Frechen D, Schoendube F, Hanrath P, Allessie MA. Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation. 2001;103:691-698.
9. Ausma J, Dispersyn GD, Duimel H, Thone F, Ver Donck L, Allessie MA, Borgers M. Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation. J Mol Cell Cardiol. 2000;32:355-364.
10. Van Wagoner DR, Nerbonne JM. Molecular basis of electrical remodeling in atrial fibrillation. J Mol Cell Cardiol. 2000;32:1101-1117.
11. 2+-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atrial electrical remodeling. J Am Coll Cardiol. 1999;33:1231-1237.
12. Sood S, Chelu MG, van Oort RJ, Skapura D, Santonastasi M, Dobrev D, Wehrens XH. Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation. Heart Rhythm. 2008; 5:1047-1054.
13. Heist EK, Ruskin JN. Atrial fibrillation and congestive heart failure: risk factors, mechanisms, and treatment. Prog Cardiovasc Dis. 2006;48: 256-269.
14. Balasubramaniam R, Kistler PM. AF and heart failure: the chicken or the egg Heart. 2000;95:535-539.
15. 2+ channel KO mouse. Am J Physiol. 2008;295: H2017-H2024.
16. Latronico MVG, Catalucci D, Condorelli G. Emerging role of MicroRNAs in cardiovascular biology. Circ Res. 2007;101:1225-1236.
17. van Rooij E, Olson EN. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest. 2007;117: 2369-2376.
18. Callis TE, Wang DZ. Taking microRNAs to heart. Trends Mol Med. 2008;14:254-260.
19. Yang B, Lu Y, Wang Z. Control of cardiac excitability by microRNAs. Cardiovasc Res. 2008;79:571-580.
20. Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature. 2005;436:214-220.
21. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA. 2006;103:18255-18260.
22. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet. 2006;38: 228-233.
23. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, Høydal M, Autore C, Russo MA, Dorn GW, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G. MicroRNA-133 controls cardiac hypertrophy. Nat Med. 2007;13:613-618.
24. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, Chen G, Wang Z. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med. 2007;13:486-491.
25. Ks-encoding genes and potential implications in regional heterogeneity of their expressions. J Cell Physiol. 2007;212:358-367.
26. Luo X, Lin H, Xiao J, Zhang Y, Lu Y, Yang B, Wang Z. Downregulation of miRNA-1/miRNA-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. J Biol Chem. 2008;283:20045-20052.
27. Luo X, Zhang H, Xiao J, Wang Z. Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications. Cell Physiol Biochem. 2010;25:571-586.
28. 2+ release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyper-phosphorylation of RyR2. Circ Res. 2009;104:514-521.
29. + channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem. 2007;282:12363-12367.
30. Xiao L, Xiao J, Luo X, Lin H, Wang Z, Nattel S. Feedback remodeling of cardiac potassium current expression: a novel potential mechanism for control of repolarization reserve. Circulation. 2008;118:983-992.
31. Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN, Tsuchihashi T, McManus MT, Schwartz RJ, Srivastava D. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell. 2007;129:303-317.
32. Matkovich SJ, Wang W, Tu Y, Eschenbacher WH, Dorn LE, Condorelli G, Diwan A, Nerbonne JM, Dorn GW II. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res. 2010;106:166-175.
33. K1 up-regulation in human atrial fibrillation. Heart Rhythm. 2009;6:1802-1809.
34. Shan H, Zhang Y, Lu Y, Zhang Y, Pan Z, Cai B, Wang N, Li X, Feng T, Hong Y, Yang B. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res. 2009;83:465-472.
35. Schrickel JW, Bielik H, Yang A, Schimpf R, Shlevkov N, Burkhardt D, Meyer R, Grohe C, Fink K, Tiemann K, Lüderitz B, Lewalter T. Induction of atrial fibrillation in mice by rapid transesophageal atrial pacing. Basic Res Cardiol. 2002;97:452-460.
36. Wakimoto H, Maguire CT, Kovoor P, Hammer PE, Gehrmann J, Triedman JK, Berul CI. Induction of atrial tachycardia and fibrillation in the mouse heart. Cardiovasc Res. 2001;50:P463-P473.
37. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing: structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Nature. 1995;91:1588-1595.
38. Brignole M, Menozzi C, Sartore B, Barra M, Monducci I. The use of atrial pacing to induce atrial fibrillation and flutter. Int J Cardiol. 1986; 12:45-54.
39. Shiroshita-Takeshita A, Schram G, Lavoie J, Nattel S. Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs. Circulation. 2004;110:2313-2319.
40. Krutzfeldt J, Rajewsky N, BraichR, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. Silencing of microRNAs in vivo with "antagomirs." Nature. 2005;438:685-689.
41. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods. 2007;4: 721-726.
42. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation. 1995;92:1954-1968.
43. Moe Gk, Rheinboldt WC, Abildskov JA. A computer model of atrial fibrillation. Am Heart J. 1964;67:200-220.
44. Boissonneault V, Plante I, Rivest S, Provost P. MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein converting enzyme 1. J Biol Chem. 2009;284:1971-1981.
45. Malzkorn B, Wolter M, Liesenberg F, Grzendowski M, Stühler K, Meyer HE, Reifenberger G. Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol. 2009;20:539-550.
46. Padgett KA, Lan RY, Leung PC, Lleo A, Dawson K, Pfeiff J, Mao TK, Coppel RL, Ansari AA, Gershwin ME. Primary biliary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun. 2009; 32:246-253.
47. Pan YZ, Morris ME, Yu AM. MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Mol Pharmacol. 2009;75:1374-1379.
48. Sanchez Freire V, Burkhard FC, Kessler TM, Kuhn A, Draeger A, Monastyrskaya K. MicroRNAs may mediate the down-regulation of neurokinin-1 receptor in chronic bladder pain syndrome. Am J Pathol. 2010;176:288-303.